October 3, 2025 · Form 4 insider transaction
Caudill Cortney bought 3,625 shares of Halozyme Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 3 days after the transaction.
This award vests one-fourth on the first anniversary of the grant date and then one-fourth on each anniversary date thereafter.